From the time the Scottish physician James Lind showed citrus cured scurvy in 1747, clinical trials have had a reputation for being gold-standard evidence about the safety and effectiveness of medical…
Articles on Cancer drugs
Displaying 41 - 42 of 42 articles
Decisions whether to publicly fund new drugs or not are often tough. Should the government fund a drug that has promising early results or wait until its effects and safety issues are better understood…
Top contributors
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor of Medical Oncology, University of Colorado Anschutz
-
Macquarie University Research Fellow, Macquarie University
-
Professor of Bioethics, Macquarie University
-
Professor of Health Economics, Flinders University
-
Clinical Professorial Research Fellow, Australian Women and Girls' Health Research Centre, The University of Queensland
-
Professor of Surgery, Division of Public Health Sciences, Washington University in St. Louis
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Research Fellow, Flinders University
-
Chair in Translational Cancer Genomics, Queen's University Belfast
-
Professor of Cellular and Molecular Neuro-Oncology, University of Portsmouth
-
Professor, Department of Health Policy, London School of Economics and Political Science
-
Professor of Health Economics, University of Technology Sydney
-
Oncologist and Senior Lecturer, University of Newcastle
-
Senior Coordinator, Communications and Events, Monash University